Imgn investors hub
Witryna11 kwi 2024 · About IMGN. ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant … Witryna6 kwi 2024 · IMGN Stock Message Board for Investors. ImmunoGen Inc. Stock Price, News and Company Updates. Message Board Total Posts: 67
Imgn investors hub
Did you know?
Witryna5 kwi 2024 · IMGN’s stock style is Small Core. Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining … WitrynaImmunoGen Inc. (NASDAQ:IMGN) has a beta value of 0.93 and has seen 2.94 million shares traded in the last trading session. The company, currently valued at $944.08M, …
WitrynaIMGN.PRO jest polskim wydawcą, dystrybutorem i producentem gier wideo przeznaczonych na komputery osobiste i konsole. Oprócz autorskich produkcji w jej portfolio wydawniczym można znaleźć ... Witryna11 kwi 2024 · About IMGN. ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's …
Witryna6 kwi 2024 · Short selling IMGN is an investing strategy that aims to generate trading profit from ImmunoGen as its price is falling. IMGN shares are trading up $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. WitrynaInstitutional Ownership and Shareholders. ImmunoGen, Inc. (US:IMGN) has 394 institutional owners and shareholders that have filed 13D/G or 13F forms with the …
Witryna10 kwi 2024 · ImmunoGen (IMGN) Investor Presentation - Slideshow Nov 20. Analysts increase revenue estimates to US$79.5m Nov 13. Third quarter 2024 earnings released: US$0.13 loss per share Nov 08. Revenue beats expectations, earnings disappoint Nov 08. ImmunoGen EPS beats by $0.06, beats on revenue
Witryna6 kwi 2024 · A high-level overview of ImmunoGen, Inc. (IMGN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. camouflage outdoor gearWitryna8 kwi 2024 · ImmunoGen, Inc. Message board - Online Community of active, educated investors researching and discussing ImmunoGen, Inc. Stocks. Home Recent Posts … first security longview texasWitryna27 lut 2024 · Business. The trading price of ImmunoGen Inc. (NASDAQ:IMGN) closed lower on Friday, February 24, closing at $3.73, -6.05% lower than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $3.655 and $3.93. In examining the 52-week price action we see … first security login missoula mtWitryna31 mar 2024 · March 31, 2024. For the readers interested in the stock health of ImmunoGen Inc. (IMGN). It is currently valued at $3.71. When the transactions were called off in the previous session, Stock hit the highs of $3.84, after setting-off with the price of $3.84. Company’s stock value dipped to $3.66 during the trading on the day. camouflage outdoor growWitryna12 mar 2007 · Presentation of MARINE and ANCHOR analyses at AHA showing significant reduction of remnant-like particle cholesterol (17 Nov 2014) Marine & … camouflage outdoor security camerasWitryna26 cze 2024 · IMGN Media has raised a total of $6M in funding over 3 rounds. Their latest funding was raised on Jun 26, 2024 from a Series A round. IMGN Media is … camouflage outdoor vinylWitryna29 mar 2024 · The table shows changes in IMGN in the past 3 months by investors with public portfolios. Investor activity updates every 24 hours. IMGN Investors Also Bought. Name. Average Holding Size. Last 7D Change. Last 30D Change. Market Cap. Sector. 3M Behavior. Follow. GE. General Electric. 6.04% +0.03% +1.95%. camouflage outerwear